NWS
62
-2
HSIC
54
-3
STI
47
-12
TEL
60
2
VFC
47
-5
ADP
64
2
VRSK
73
5
NTAP
64
2
COP
56
2
GIS
26
3
GM
65
-3
HPE
55
11
NWL
44
-4
MTCH
37
7
FMC
31
5
PX
75
5
FRT
39
-2
JNPR
46
3
SIG
43
3
GOOGL
54
-2
NWS
62
-2
HSIC
54
-3
STI
47
-12
TEL
60
2
VFC
47
-5
ADP
64
2
VRSK
73
5
NTAP
64
2
COP
56
2
GIS
26
3
GM
65
-3
HPE
55
11
NWL
44
-4
MTCH
37
7
FMC
31
5
PX
75
5
FRT
39
-2
JNPR
46
3
SIG
43
3
GOOGL
54
-2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

TGTX
TG Therapeutics

Last Price:
34.51
Seasonality Move:
52.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

TG Therapeutics Price Quote

$34.51
+3.36 (+10.79%)
(Updated: November 21, 2024 at 5:55 PM ET)

TG Therapeutics Key Stats

Buy
58
TG Therapeutics (TGTX) is a Buy
Day range:
$29.91 - $32.00
52-week range:
$11.86 - $36.50
Dividend yield:
0%
P/E ratio:
329.00
P/S ratio:
17.40
P/B ratio:
23.99%
Volume:
2.2M
Avg. volume:
3.6M
1-year change:
142.98%
Market cap:
$4.6B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 33.63% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 142.98% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $244.2M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.23

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$28.1M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $134.6M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$61.6M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -4.78%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Inspire Medical Systems Inc (INSP)
    • Mirum Pharmaceuticals Inc (MIRM)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 37.22
Upside from Last Price: 19.49%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    170.5M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders